Wei‐Ting Hwang

26.6k citations

271 papers · 14.1k indexed · 6 hit papers · h-index 55

Oncology top 0.2%
- CAR-T cell therapy research 38
- Cancer Immunotherapy and Biomarkers 20
Cancer Research top 0.5%
- Breast Cancer Treatment Studies 31
Virology top 1%
Research and Theory top 2%
Immunology top 1%
Surgery
- Bladder and Urothelial Cancer Treatments 22
- Urinary and Genital Oncology Studies 17
Pulmonary and Respiratory Medicine
- Lung Cancer Treatments and Mutations 19
Pathology and Forensic Medicine
- Breast Lesions and Carcinomas 18
Pediatrics, Perinatology and Child Health
- Childhood Cancer Survivors' Quality of Life 17

Co-authors: Ann E. Rogers Linda D. Scott Lawrence J. Solin Carl H. June Eleanor Harris Bruce L. Levine David F. Dinges Anne E. Kazak
Cited by: Oncology Cancer Research Virology
Journals: Journal of Clinical Oncology (36 papers)International Journal of Radiation Oncology*Biology*Physics (28 papers)Blood (17 papers)
Partner nations: United States Egypt Netherlands

In The Last Decade

Wei‐Ting Hwang

261 papers receiving 13.6k citations

Hit Papers

6 papers align trajectories log scale

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

2015 Science Translational Medicine
2015 New England Journal of Medicine
2014 New England Journal of Medicine
2012 Science Translational Medicine
2011 Gynecologic Oncology
2004 Health Affairs

Peers

Countries citing papers authored by Wei‐Ting Hwang

Since Specialization

Citations

This map shows the geographic impact of Wei‐Ting Hwang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Wei‐Ting Hwang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Wei‐Ting Hwang more than expected).

Fields of papers citing papers by Wei‐Ting Hwang

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Wei‐Ting Hwang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Wei‐Ting Hwang. The network helps show where Wei‐Ting Hwang may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Wei‐Ting Hwang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Wei‐Ting Hwang Line = papers co-authored together Wei‐Ting Hwang links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Low- vs High-Dose 5-FU in Triplet Chemotherapy Plus Bevacizumab for Patients With Colorectal Cancer JAMA Network Open ·William J. Chapin,Wei‐Ting Hwang,Ronac Mamtani,Mark H. O’Hara	2024	1
2	P2.31-05 Determining Lines of Therapy in Patients with Metastatic Non-Small Cell Lung Cancer Using Real-World Data Journal of Thoracic Oncology ·Tracy Ann Hudgins,Lova Sun,Joshua E. Reuss,V. Lund,Geoffrey Liu,大庭理寛,Stephen V. Liu,(unknown),Tejas Patil,Jorge J. Nieva,Jörg Stoffregen,Kristen A. Marrone,Vincent K. Lam,William Schwartzman,Maria Magalhães Vasconcelos Guedes,Keith L. Miller,D. Ross Camidge,Charu Aggarwal,Wei‐Ting Hwang,Melina E. Marmarelis	2023	0
3	CTIM-40. EARLY RADIOGRAPHIC RESPONSE AND ENGRAFTMENT OF PHASE I FIRST-IN-HUMAN BICISTRONIC CAR T CELLS CORRELATE WITH REAL-TIME AUTOLOGOUS GBM ORGANOID CYTOLYSIS Neuro-Oncology ·Meghan Logun,Stephen Bagley,Г.Г. Нубаева,Daniel Zhang,Yusha Sun,Guo‐li Ming,Ali Nabavizadeh,Amy Marshall,Eileen Maloney,Wei‐Ting Hwang,Joseph A. Fraietta,Vanessa Gonzalez,Arati Desai,Linda J. Bagley,Elizabeth O. Hexner,MacLean P. Nasrallah,Hongjun Song,Zev A. Binder,Donald M. O’Rourke	2023	1
4	Association Between Availability of Molecular Genotyping Results and Overall Survival in Patients With Advanced Nonsquamous Non–Small-Cell Lung Cancer JCO Precision Oncology ·Charu Aggarwal,Melina E. Marmarelis,Wei‐Ting Hwang,Plitnick BA,Xiang Liu,Aditi P. Singh,Lova Sun,John A. Kosteva,刘丹忱,Roger B. Cohen,Corey J. Langer,Abigail Doucette,Peter Gabriel,Lawrence N. Shulman,Katharine A. Rendle,Jeffrey C. Thompson,Justin E. Bekelman,Erica L. Carpenter	2023	22
5	C ombination A TR (ceralasertib) and P A R P (olaparib) I nhibitor (CAPRI) Trial in Acquired PARP Inhibitor–Resistant Homologous Recombination–Deficient Ovarian Cancer Clinical Cancer Research ·Stephanie L. Wethington,Payal D. Shah,Lainie P. Martin,János L. Tanyi,Nawar Latif,Mark A. Morgan,Drew A. Torigian,Ayesha Asghar,Simon A. Smith,Emma Dean,Susan M. Domchek,Ronny Drapkin,Ie−Ming Shih,Eric J. Brown,Wei‐Ting Hwang,Deborah K. Armstrong,Stéphanie Gaillard,Robert Giuntoli,Fiona Simpkins	2023	40
6	Liquid Chromatography–Mass Spectrometry Analysis of Frataxin Proteoforms in Whole Blood as Biomarkers of the Genetic Disease Friedreich’s Ataxia Analytical Chemistry ·María de la Mar Bustamante,Linfeng Wu,Tracy Ann Hudgins,Wei‐Ting Hwang,Clementina Mesaros,David R. Lynch,Ian A. Blair	2023	9
7	Characteristics of long-term survivors with EGFR mutant (EGFRm) metastatic non-small cell lung cancer (mNSCLC). Journal of Clinical Oncology ·Melina E. Marmarelis,Tracy Ann Hudgins,Caroline E. McCoach,А.Е. Горовая,Geoffrey Liu,Devalben Patel,Jorge J. Nieva,Kristen A. Marrone,Vamsidhar Velcheti,Stephen V. Liu,Tejas Patil,Jared Weiss,William Schwartzman,Liza C. Villaruz,Wolski Marcin,Dara L. Aisner,Wei‐Ting Hwang,Charu Aggarwal,D. Ross Camidge,Lova Sun	2023	0
8	Statistical Considerations for Analyses of Time-To-Event Endpoints in Oncology Clinical Trials: Illustrations with CAR-T Immunotherapy Studies Clinical Cancer Research ·Yimei Li,Wei‐Ting Hwang,Shannon L. Maude,David T. Teachey,Noelle V. Frey,Regina M. Myers,Allison Barz Leahy,Putu Agus Grantika,David L. Porter,Stephan A. Grupp,Pamela A. Shaw	2022	8
9	Real-world effectiveness of CPX-351 vs venetoclax and azacitidine in acute myeloid leukemia Blood Advances ·Andrew Matthews,Alexander E. Perl,Selina M. Luger,Alison W. Loren,Saar Gill,David L. Porter,Daria V. Babushok,Ivan Maillard,Martin Carroll,Noelle V. Frey,Elizabeth O. Hexner,Mary Ellen Martin,Shannon R. McCurdy,Edward A. Stadtmauer,Vikram R. Paralkar,Nilson Maia,Wei‐Ting Hwang,David M. Margolis,Keith W. Pratz	2022	53
10	Modeling post-holiday surge in COVID-19 cases in Pennsylvania counties PLoS ONE ·Mazuba Mwanachingwala,Wei‐Ting Hwang	2022	2
11	Comparison of nivolumab and sorafenib for first systemic therapy in patients with hepatocellular carcinoma and Child‐Pugh B cirrhosis Cancer Medicine ·William J. Chapin,Wei‐Ting Hwang,Thomas B. Karasic,Anne Marie McCarthy,David E. Kaplan	2022	15
12	Outcomes in Patients With Non–small-cell Lung Cancer With Brain Metastases Treated With Pembrolizumab-based Therapy Clinical Lung Cancer ·Lova Sun,Christiana Davis,Wei‐Ting Hwang,Natalia Andrea Santofimio Luján,Lake Ontario Sediments,Melina E. Marmarelis,Aditi P. Singh,Abigail T. Berman,Steven J. Feigenberg,William P. Levin,Christine Ciunci,Joshua Bauml,Roger B. Cohen,Corey J. Langer,Charu Aggarwal	2020	30
13	Function of Human Tumor-Infiltrating Lymphocytes in Early-Stage Non–Small Cell Lung Cancer Cancer Immunology Research ·Shaun O’Brien,Astero Klampatsa,Jeffrey C. Thompson,Marina C. Martinez,Wei‐Ting Hwang,Bartholomew Moore,Oziel Saturnino,Soyeon Kim,Edward Cantu,Leslie A. Litzky,Sunil Singhal,Evgeniy Eruslanov,Edmund K. Moon,Steven Μ. Albelda	2019	67
14	Diastolic dysfunction in tetralogy of Fallot: Comparison of echocardiography with catheterization Echocardiography ·Michael P. DiLorenzo,Wei‐Ting Hwang,Elizabeth Goldmuntz,Bonnie Ky,Laura Mercer‐Rosa	2018	22
15	Dynamic Contrast-Enhanced MRI–Derived Intracellular Water Lifetime (τ_i): A Prognostic Marker for Patients with Head and Neck Squamous Cell Carcinomas American Journal of Neuroradiology ·Sanjeev Chawla,Laurie A. Loevner,Sungheon Kim,Wei‐Ting Hwang,Silvio Joaquim Lopes,Gaurav Verma,Suyash Mohan,Virginia A. LiVolsi,Harry Quon,Harish Poptani	2017	22
16	Effects of BRCA1 - and BRCA2 -Related Mutations on Ovarian and Breast Cancer Survival: A Meta-analysis Clinical Cancer Research ·Qian Zhong,Hongling Peng,Xia Zhao,Lin Zhang,Wei‐Ting Hwang	2014	140
17	Upfront Androgen Deprivation Therapy With Salvage Radiation May Improve Biochemical Outcomes in Prostate Cancer Patients With Post-Prostatectomy Rising PSA International Journal of Radiation OncologyBiologyPhysics ·Joanne Jang,Wei‐Ting Hwang,Thomas J. Guzzo,Alan J. Wein,Naomi B. Haas,Stefan Both,Neha Vapiwala	2012	13
18	Coronary Artery Findings After Left-Sided Compared With Right-Sided Radiation Treatment for Early-Stage Breast Cancer Journal of Clinical Oncology ·Candace R. Correa,Harold Litt,Wei‐Ting Hwang,Victor A. Ferrari,Lawrence J. Solin,Eleanor Harris	2007	303
19	Effect of GB virus C viremia on HIV acquisition and HIV set-point AIDS ·Gregory P. Bisson,Brian L. Strom,Robert Gross,Drew Weissman,Donna Klinzman,Wei‐Ting Hwang,Jay R. Kostman,David S. Metzger,Jack T. Stapleton,Ian Frank	2005	10
20	Feasibility and Preliminary Outcomes from a Pilot Study of a Brief Psychological Intervention for Families of Children Newly Diagnosed with Cancer Journal of Pediatric Psychology ·Anne E. Kazak,Steven Simms,Melissa A. Alderfer,Mary T. Rourke,M Werber,Kelly S. McClure,Shahnaj Hussain Mazumder,Alyssa Rodriguez,周建明,Wei‐Ting Hwang,Anne F. Reilly	2005	164

About Wei‐Ting Hwang

Wei‐Ting Hwang is a scholar working on Oncology, Cancer Research and Pathology and Forensic Medicine, having authored 271 papers that have together received 14.1k indexed citations. Recurring topics across this work include CAR-T cell therapy research (38 papers), Breast Cancer Treatment Studies (31 papers), Bladder and Urothelial Cancer Treatments (22 papers), Cancer Immunotherapy and Biomarkers (20 papers), Lung Cancer Treatments and Mutations (19 papers), Breast Lesions and Carcinomas (18 papers), Urinary and Genital Oncology Studies (17 papers) and Childhood Cancer Survivors' Quality of Life (17 papers). The work is most often cited by research in Oncology (5.5k citations), Cancer Research (1.9k citations) and Virology (505 citations). Wei‐Ting Hwang has collaborated with scholars based in United States, Egypt and Netherlands. Frequent co-authors include Ann E. Rogers, Linda D. Scott, Lawrence J. Solin, Carl H. June, Eleanor Harris, Bruce L. Levine, David F. Dinges, Anne E. Kazak, Linda H. Aiken and J. Joseph Melenhorst. Their work appears in journals such as Journal of Clinical Oncology, International Journal of Radiation Oncology*Biology*Physics, Blood, Cancer and Journal of Pediatric Psychology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact